References
- Aanouz, I., Belhassan, A., El-Khatabi, K., Lakhlifi, T., El-Ldrissi, M., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of Biomolecular Structure and Dynamics, 6, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758790
- Abdelli, I., Hassani, F., Brikci, B., & Ghalem, S. (2020). S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics, 14, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1763199
- Adeoye, A. O., Oso, B. J., Olaoye, I. F., Tijjani, H., & Adebayo, A. I. (2020). Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. Journal of Biomolecular Structure & Dynamics.https://doi.org/https://doi.org/10.1080/07391102.2020.1765876
- Ahmad, S., Abbasi, H. W., Shahid, S., Gul, S., & Abbasi, S. W. (2020). Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: A computational quest to identify potential natural antiviral for COVID-19 treatment. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1775129
- Al-Khafaji, K., Al-Duhaidahawi, D., & Tok, T. (2020). Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 15, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1764392
- Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015). DOCK 6: Impact of new features and current docking performance. Journal of Computational Chemistry, 36(15), 1132–1156. https://doi.org/https://doi.org/10.1002/jcc.23905
- Amin, M., & Abbas, G. (2020). Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs. Journal of Biomolecular Structure and Dynamics, 29, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1775703
- Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450–452. https://doi.org/https://doi.org/10.1038/s41591-020-0820-9
- Anwar, F., Altayb, H. N., Al-Abbasi, F. A., Al-Malki, A. L., Kamal, M. A. & Kumar, V. (2020). Antiviral effects of probiotic metabolites on COVID-19. Journal of Biomolecular Structure and Dynamics, 9, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1775123
- Arya, A., & Dwivedi, V. D. (2020). Synergistic effect of vitamin D and remdesivir can fight C OVID-19. Journal of Biomolecular Structure and Dynamics, 9, 1–2. https://doi.org/https://doi.org/10.1080/07391102.2020.1773929
- Asai, A., Konno, M., Ozaki, M., Otsuka, C., Vecchione, A., Arai, T., Kitagawa, T., Ofusa, K., Yabumoto, M., Hirotsu, T., Taniguchi, M., Eguchi, H., Doki, Y., & Ishii, H. (2020). COVID-19 drug discovery using intensive approaches. International Journal of Molecular Sciences, 21(8), 2839. https://doi.org/https://doi.org/10.3390/ijms, 21082839.
- Babadaei, M. M. N., Hasan, A., Bloukh, S. H., Edis, Z., Sharifi, M., Kachooei, E., & Falahati, M. (2020). The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: Lung and heart tissue as targets. Journal of Biomolecular Structure and Dynamics, 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1767211
- Babadaei, M. M. N., Hasan, A., Vahdani, Y., Bloukh, S. H., Sharifi, M., Kachooei, E., Haghighat, S., & Falahati, M. (2020). Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1767210
- Baron, S. A., Devaux, C., Colson, P., Raoult, D., & Rolain, J. M. (2020). Teicoplanin: An alternative drug for the treatment of COVID-19? International Journal of Antimicrobial Agents, 55(4), 105944. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020.105944
- Basit, A., Ali, T., & Rehman, S. U. (2020). Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1768150
- Bauer, D. C., Tay, A. P., Wilson, L. O. W., Reti, D., Hosking, C., McAuley, A. J., Pharo, E., Todd, S., Stevens, V., Neave, M. J., Tachedjian, M., Drew, T. W., & Vasan, S. S. (2020). Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak. Transboundary and Emerging Diseases, 67(4), 1453–1462. https://doi.org/https://doi.org/10.1111/tbed.13588
- Beura, S., & Chetti, P. (2020). In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 8, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1772111
- Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1766572.
- Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 30, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1758788
- Borkotoky, S., & Banerjee, M. (2020). A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). Journal of Biomolecular Structure and Dynamics, 28, 1–17. https://doi.org/https://doi.org/10.1080/07391102.2020.1774419
- Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, 178, 104787. https://doi.org/https://doi.org/10.1016/j.antiviral.2020.104787
- Case, D. A., Betz, R. M., Cerutti, D. S, Cheatham, T. E., Darden, T. A., Duke, R. E., Giese, T. J., Gohlke, H., Goetz, A. W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T. S., LeGrand, S., Li, P., Lin, C., Luchko, T., … Kollman, P. A. (2016). AMBER 2016. University of California.
- Center for Drug Evaluation and Research (U.S.). (2004). Drugs@FDA. U.S. Food and Drug Administration, Center for Drug and Evaluation Research.
- Chandra, A., Gurjar, V., Qamar, I., & Singh, N. (2020). Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: A drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure and Dynamics, 9, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1775127
- Chen, Y. W., Yiu, C. B., & Wong, K. Y. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research, 9, 129. https://doi.org/https://doi.org/10.12688/f1000research, 22457.2
- Cherian, S. S., Agrawa, M., Basu, A., Abraham, P., Gangakhedkar, R. R., & Bhargava, B. (2020). Perspectives for repurposing drugs for the coronavirus disease 2019. Indian Journal of Medical Research, 151(2), 160–171. https://doi.org/https://doi.org/10.4103/ijmr.IJMR_585_20.
- Chodera, J. D., & Noé, F. (2014). Markov state models of biomolecular conformational dynamics. Current Opinion in Structural Biology, 25, 135–144. https://doi.org/https://doi.org/10.1016/j.sbi.2014.04.002
- Chodera, J. D., Singhal, N., Pande, V. S., Dill, K. A., & Swope, W. C. (2007). Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics. The Journal of Chemical Physics, 126(15), 155101–17461665. https://doi.org/https://doi.org/10.1063/1.2714538
- Choudhury, C. (2020). Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease. Journal of Biomolecular Structure and Dynamics, 1, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1771424
- Das, S., Sarmah, S., Lyndem, S., & Roy, S. (2020). A. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 13, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
- de Oliveira, O. V., Rocha, G. B., Paluch, A. S., & Costa, L. T. (2020). Repurposing approved drugs as inhibitors of SARS-CoV-2? S-protein from molecular modeling and virtual screening. Journal of Biomolecular Structure and Dynamics, 2, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1772885
- Elfiky, A. A. (2020a). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117477
- Elfiky, A. A. (2020b). Natural products may interfere with SARS-CoV-2 attachment to the host cell. Journal of Biomolecular Structure and Dynamics, 5, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1761881
- Elfiky, A. A. (2020c). Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
- Elfiky, A. A. (2020d). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silicoperspective. Journal of Biomolecular Structure and Dynamics, 6, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1761882
- Elfiky, A. A., & Azzam, E. B. (2020). Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 27, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758789
- Elmezayen, A. D., Al-Obaidi, A., Sahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 26, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1758791
- Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 5, 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1760136
- Ester, M., Kriegel, H., Sander, J., & Xu, X. (1996). A density-based algorithm for discovering clusters in large spatial databases with noise. Proceedings of the Second International Conference on Knowledge Discovery and Data Mining (KDD-96), ACM-Digital Library (pp. 226–231).
- Fan, H. H., Wang, L. Q., Liu, W. L., An, X. P., Liu, Z. D., He, X. Q., Song, L. H., & Tong, Y. G. (2020). Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model. Chinese Medical Journal, 133(9):1051–1056. https://doi.org/ https://doi.org/https://doi.org/10.1097/CM9.0000000000000797
- Fearon, D., Owen, C. D., Douangamath, A., Lukacik, P., Powell, A. J., Strain-Damerell, C. M., Resnick, E., Krojer, T., Gehrtz, P., Wild, C., Aimon, A., Brandao-Neto, J., Carbery, A., Dunnett, L., Skyner, R., Snee, M., London, N., Walsh, M. A., & von Delft, F. (2020). PanDDA analysis group deposition of SARS-CoV-2 mainprotease fragment screen. RCSB-PDB.
- Forster, P., Forster, L., Renfrew, C., & Forster, M. (2020). Phylogenetic network analysis of SARS-CoV-2 genomes. Proceedings of the National Academy of Sciences of the United States of America, 8, 202004999. https://doi.org/ https://doi.org/https://doi.org/10.1073/pnas.2004999117
- Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends, 14(1), 72–73. https://doi.org/https://doi.org/10.5582/bst.2020.01047
- Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L. and Tummino, T. A. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. https://doi.org/ https://doi.org/https://doi.org/10.1038/s41586-020-2286-9
- Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020a). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 15, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1751300
- Gupta, S., Singh, A. K., Kushwaha, P. P., Prajapati, K. S., Shuaib, M., Senapati, S., & Kumar, S. (2020b). Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies. Journal of Biomolecular Structure and Dynamics, 1, 1–19. https://doi.org/https://doi.org/10.1080/07391102.2020.1776157
- Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 18, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1764868
- Hall, D. C., Jr., & Ji, H. F. (2020). A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Medicine and Infectious Disease, 35, 101646. https://doi.org/https://doi.org/10.1016/j.tmaid.2020.101646
- Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., Shahpasand, K., Saboury, A. A., & Falahati, M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 22, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1754293
- Hendaus, M. A. (2020). Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1767691.
- Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. A. (2020). Molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 12, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
- Jani, V., Sonavane, U., & Joshi, R. (2019). Detecting early stage structural changes in wild type, pathogenic and non-pathogenic prion variants using Markov state model. RSC Advances, 9(25), 14567–14579. https://doi.org/https://doi.org/10.1039/C9RA01507H
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of M(pro) from COVID-19 virus and discovery of its inhibitors. Nature, 598, 289–293 https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics, 5, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1760137
- Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
- Khan, M. T., A. A., Wang, Q., Irfan, M., Khan, A., Zeb, M. T., Zhang, Y. J., Chinnasamy, S., & Wei, D. Q. (2020a). Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study. Journal of Biomolecular Structure and Dynamics, 1, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1769733
- Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020b). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577.
- Khan, S. A., Ashraf, Z. K., Uddin, S., & Ul-Haq, R. (2020c). Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 13, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1751298
- Kim, D., Lee, J. Y., Yang, J. S., Kim, J. W., Kim, V. N., & Chang, H. (2020). The architecture of SARS-CoV-2 transcriptome. Cell, (20), 30402–30406. https://doi.org/https://doi.org/10.1016/j.cell.2020.04.011
- Komatsu, T. S., Koyama, Y. M., Okimoto, N., Morimoto, G., Ohno, Y., & Taiji, M. (2020). COVID-19 related trajectory data of 10 microseconds all atom molecular dynamics simulation of SARS-CoV-2 dimeric main protease. Mendeley Data, v1. https://doi.org/https://doi.org/10.17632/vpps4vhryg.1
- Kruse, R. L. (2020). Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Research, 9, 72. https://doi.org/https://doi.org/10.12688/f1000research.22211.2
- Kumar, A., Choudhir, G., Shukla, S. K., Sharma, M., Tyagi, P., Bhushan, A., & Rathore, M. (2020a). Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics, 4, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1772112
- Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K., Chandra, R., & Singh, P. (2020b). Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. Journal of Biomolecular Structure and Dynamics, 4, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1752310
- Kumar, V., Dhanjal, J. K., Bhargava, P., Kaul, A., Wang, J., Zhang, H., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020c). Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. Journal of Biomolecular Structure and Dynamics, 29, 1–27. https://doi.org/https://doi.org/10.1080/07391102.2020.1775704
- Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020d). Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics, 1, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1772108
- Kuzmanic, A., Bowman, G. R., Juarez-Jimenez, J., Michel, J., & Gervasio, F. L. (2020). Investigating cryptic binding sites by molecular dynamics simulations. Accounts of Chemical Research, 53(3), 654–661. https://doi.org/https://doi.org/10.1021/acs.accounts.9b00613
- Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/https://doi.org/10.1021/ci200227u
- Li, C., Yang, Y., & Ren, L. (2020). Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 82, 104285. https://doi.org/https://doi.org/10.1016/j.meegid.2020.104285
- Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews Drug Discovery, 19(3), 149–150. https://doi.org/https://doi.org/10.1038/d41573-020-00016-0
- Liu, S., Zheng, Q., & Wang, Z. (2020). Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus. Bioinformatics (Oxford, England), 36(11), 3295–3298. https://doi.org/https://doi.org/10.1093/bioinformatics/btaa224
- Lobo-Galo, N., Terrazas-López, M., Martínez-Martínez, A., & Díaz-Sánchez, Á. G. (2020). FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics, 14, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1764393
- Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020). Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: An in silico based approach. Journal of Biomolecular Structure and Dynamics, 25, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1768902
- Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. (2020). Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics, 20, 1–19. https://doi.org/https://doi.org/10.1080/07391102.2020.1768151
- Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 16, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802
- Nadeem, M. S., Zamzami, M. A., Choudhry, H., Murtaza, B. N., Kazmi, I., Ahmad, H., & Shakoori, A. R. (2020). Origin, potential therapeutic targets and treatment for coronavirus disease (COVID-19). Pathogens, 9(4), 307. https://doi.org/https://doi.org/10.3390/pathogens9040307
- Novick, P. A., Ortiz, O. F., Poelman, J., Abdulhay, A. Y., & Pande, V. S. (2013). SWEETLEAD: An in silico database of approved drugs, regulated chemicals, and herbal isolates for computer-aided drug discovery. PLoS One, 8(11), e79568. https://doi.org/https://doi.org/10.1371/journal.pone.0079568
- Ortega, J. T., Serrano, M. L., Pujol, F. H., & Rangel, H. R. (2020). Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target. EXCLI Journal, 19, 400–409.
- Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 6, 1–10.
- Pawar, A. Y. (2020). Combating Devastating COVID -19 by Drug Repurposing. International Journal of Antimicrobial Agents, 105984. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020.105984
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084
- Phadke, M., & Saunik, S. (2020). COVID-19 treatment by repurposing drugs until the vaccine is in sight. Drug Development Research. https://doi.org/https://doi.org/10.1002/ddr.21666
- Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., Bansal, S., & Medhi, B. (2020). Drug targets for corona virus: A systematic review. Indian Journal of Pharmacology, 52(1), 56–65. https://doi.org/https://doi.org/10.4103/ijp.IJP_115_20
- Prinz, J. H., Wu, H., Sarich, M., Keller, B., Senne, M., Held, M., Chodera, J. D., Schütte, C., & Noé, F. (2011). Markov models of molecular kinetics: Generation and validation. The Journal of Chemical Physics, 134(17), 174105. https://doi.org/https://doi.org/10.1063/1.3565032
- Quimque, M. T. J., Notarte, K. I. R., Fernandez, R. A. T., Mendoza, M. A. O., Liman, R. A. D., Lim, J. A. K., Pilapil, L. A. E., Ong, J. K. H., Pastrana, A. M., Khan, A., Wei, D. Q., & Macabeo, A. (2020). Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics, 1, 1–23. https://doi.org/https://doi.org/10.1080/07391102.2020.1776639
- Rosa, S. G. V., & Santos, W. C. (2020). Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Salud Pública, 44, e40. https://doi.org/https://doi.org/10.26633/RPSP.2020.40
- Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443–W447. https://doi.org/https://doi.org/10.1093/nar/gkv315
- Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 18, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1753580
- Scherer, M. K., Trendelkamp-Schroer, B., Paul, F., Pérez-Hernández, G., Hoffmann, M., Plattner, N., Wehmeyer, C., Prinz, J. H., & Noé, F. (2015). PyEMMA 2: A software package for estimation, validation, and analysis of Markov models. Journal of Chemical Theory and Computation, 11(11), 5525–5542. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00743
- Serafin, M. B., Bottega, A., Foletto, V. S., da Rosa, T. F., Hörner, A., & Hörner, R. (2020). Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, 55(6), 105969. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020.105969
- Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252, 117652. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117652
- Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics, 13, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1762741
- Sirur, A., De Sancho, D., & Best, R. B. (2016). Markov state models of protein misfolding. The Journal of Chemical Physics, 144(7), 075101. https://doi.org/https://doi.org/10.1063/1.4941579
- Sk, M. F., Roy, R., Jonniya, N. A., Poddar, S., & Kar, P. (2020). Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics, 1, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1768149
- Smith, M., & Smith, J. C. (2020). Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. ChemRxiv. Preprint. https://doi.org/https://doi.org/10.26434/chemrxiv.11871402.v4
- Stefanelli, P., Faggioni, G., Lo Presti, A., Fiore, S., Marchi, A., Benedetti, E., Fabiani, C., Anselmo, A., Ciammaruconi, A., Fortunato, A., De Santis, R., Fillo, S., Capobianchi, M. R., Gismondo, M. R., Ciervo, A., Rezza, G., Castrucci, M. R., Lista, F., & On Behalf of ISS COVID-19 Study Group. (2020). Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: Additional clues on multiple introductions and further circulation in Europe. Euro Surveill, 25(13). https://doi.org/https://doi.org/10.2807/1560-7917.ES.2020.25.13.2000305
- Tu, Y. F., Chien, C. S., Yarmishyn, A. A., Lin, Y. Y., Luo, Y. H., Lin, Y. T., Lai, W. Y., Yang, D. M., Chou, S. J., Yang, Y. P., Wang, M. L., & Chiou, S. H. (2020). A review of SARS-CoV-2 and the ongoing clinical trials. International Journal of Molecular Sciences, 21(7), 2657. https://doi.org/https://doi.org/10.3390/ijms, 21072657
- Umesh, Kundu, D., Selvaraj, C., Singh, S. K., & Dubey, V. K. (2020). Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics, 2, 1–9. https://doi.org/1080/07391102.2020.1763202
- Vangone, A., Schaarschmidt, J., Koukos, P., Geng, C., Citro, N., Trellet, M. E., Xue, L. C., & Bonvin, A. (2019). Large-scale prediction of binding affinity in protein-small ligand complexes: The PRODIGY-LIG web server. Bioinformatics (Oxford, England), 35(9), 1585–1587. https://doi.org/https://doi.org/10.1093/bioinformatics/bty816
- Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics, 12, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1762743
- Wang, C., Liu, Z., Chen, Z., Huang, X., Xu, M., He, T., & Zhang, Z. (2020). The establishment of reference sequence for SARS-CoV-2 and variation analysis. Journal of Medical Virology, 92(6), 667–674. https://doi.org/https://doi.org/10.1002/jmv.25762
- World Health Organization. WHO. https://covid19.who.int/
- Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). Author correction: A new coronavirus associated with human respiratory disease in China. Nature, 580(7803), E7. https://doi.org/https://doi.org/10.1038/s41586-020-2202-3
- Xu, D., Zhang, Z., Jin, L., Chu, F., Mao, Y., Wang, H., Liu, M., Wang, M., Zhang, L., Gao, G. F., & Wang, F. S. (2005). The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases, 24(3), 165–171. https://doi.org/https://doi.org/10.1007/s10096-020-03899-4
- Yadav, P. D., Potdar, V. A., Choudhary, M. L., Nyayanit, D. A., Agrawal, M., Jadhav, S. M., Majumdar, T. D., Shete-Aich, A., Basu, A., Abraham, P., & Cherian, S. S. (2020). Full-genome sequences of the first two SARS-CoV-2 viruses from India. Indian Journal of Medical Research, 151(2), 200-209. https://doi.org/https://doi.org/10.4103/ijmr.IJMR_663_20
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors. Science, 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405